ConferencePoster
 (2023)

Nivolumab (NIVO) plus chemotherapy (chemo) vs chemo as first-line (1L) treatment for advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC): 3-year follow-up from CheckMate 649

GARRIDO, Marcelo; Gallardo, Carlos; Bragagnoli, Arinilda Silva Campos et al.